Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis

Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis

(2015) Chao-Ying Gu et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma

(2015) Smitha R. Georgy et al.   JNCI-Journal of the National Cancer Institute

Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma

(2015) Smitha R. Georgy et al.   JNCI-Journal of the National Cancer Institute

Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: Potential as a serum biomarker

(2014) Jong-Baeck Lim et al.   CANCER SCIENCE

Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis

(2014) Denny L. Cottle et al.   HUMAN MOLECULAR GENETICS

A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia

(2014) William M. Gordon et al.   JOURNAL OF CLINICAL INVESTIGATION

Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis

(2014) Yoko Kataoka   JOURNAL OF DERMATOLOGY

Stem Cells behind the Barrier

(2013) Michael Cangkrama et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata

(2013) Shigeki Inui et al.   JOURNAL OF DERMATOLOGY

Psoriasis

(2011) Gayathri K. Perera et al.   Annual Review of Pathology-Mechanisms of Disease

Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate

(2010) E. N. Arwert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA